Do lipoxygenases modulate normal or aberrant lympho-hematopoiesis?

Leukemia Research

Volumn 23, Issue 1, 1999, Pages 51-56

  Anderson, K M ^a   Ondrey, F ^b   Harris, J E ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Aberrant lympho hematopoiesis; Lipoxygenases; Normal lympho hematopoiesis

Indexed keywords

LIPOXYGENASE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; HEMATOPOIESIS; LYMPHOPOIESIS; PRIORITY JOURNAL;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONATE LIPOXYGENASES; ENZYME INHIBITORS; GENE TARGETING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS;

EID: 0032890029     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00130-1     Document Type: Article

References (50)

1. Jing Y, Nakajo S, Xia L et al, 1998. Boswellic acid acetate induces differentiation and apoptosis in leukemia cell lines. Leuk Res (this issue).
2. Anderson, KM, Wiederhold, M, Ondrey, F, 1994. Participation of lipoxygenase products in lymphohematopoietic and other cell proliferation and differentiation. In: Harris JE, Braun DP, Anderson KM, editors, Prostaglandin Inhbitors in Tumor Immunology and Immunotherapy. CRC Press, Boca Raton, FL, pp. 41-72.
3. Funk CD. The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice. Biochim Biophys Acta 1996;1304:65-84.
4. Bray D. Intracellular signaling as a parallel distributed process. J Theor Biol 1990;141:215-31.
5. Chen X-S, Funk CD, 1998. 5-Lipoxygenase deficiency-induced cell growth arrest and apoptosis in mouse mast cells. 5th Int Conf on Eicosanoids, LaJolla, CA, abstract 95.
6. Miller AM, Weiner RS, Ziboh VA. Evidence for the role of leukotrienes C4 and D4 as essential intermediates in CSF-stimulated human myeloid colony formation. Exp Hematol 1986;14:760-7.
7. Claesson HE, Dahlberg N, Gahrton G. Stimulation of human myelopoiesis by leukotriene B4. Biochem Biophys Res Commun 1985;131:579-85.
8. Tsukada T, Nakashima K, Shirakawa S. Arachidonic 5-lipoxygenase inhibitors show potent antiproliferative effects on human leukemia cell lines. Biochem Biophys Res Commun 1986;140:832-6.
9. Synder DS, Castro R, DesForges JF. Antiproliferative effects of lipoxygenase inhibitors on malignant hematopoietic cell lines. Exp Hematol 1989;17:6-9.
10. Lawrence JH, Suyehira LA, Hack FM. Differential sensitivity of human myeloid leukemia cells to the antiproliferative effects of 5′-lipoxygenase inhibitors. Blood 1986;68:145a.
11. Vore SJ, Eling TE, Dabilowicz RM, et al. Regulation of murine hematopoiesis by arachidonic acid metabolites. Int J Immunopharmacol 1989;11:435-42.
12. Ondrey F, Harris JE, Anderson KM. Inhibition of U937 eicosanoid and DNA synthesis by 5,8,11,14-eicosatetraynoic acid, an inhibitor of arachidonic acid metabolism and its partial reversal by leukotriene C4. Cancer Res 1989;49:1138-42.
13. Estov Z, Haiperin DS, Coceani F, Freedman MH. Modulation of human marrow haematopoiesis by leucotrienes in vitro. Br J Haematol 1988;69:321-7.
14. Pasquale D, Chiokkappa G. Lipoxygenase products regulate proliferation of granulocyte-macrophage progenitors. Exp Hematol 1993;21:1311-65.
15. Khan MA, Hoffbrand AV, Mehta A, et al. MK885, an antagonist of leukotriene generation, inhibits DNA synthesis in a subset of acute myeloid leukaemia cells. Leuk Res 1993;17(9):759-62.
16. Khan MA, Tateson JE, Hoffbrand AV, Wickremasinghe RG. Evidence that endogenous generation of leukotrienes does not regulate proliferation of malignant hemopoietic cell lines. Leuk Res 1993;17(3):241-5.
17. Wickremasinghe RG, Khan MA, Hoffbrand AV. Do leukotrienes play a role in the regulation of proliferation of normal and leukemia hemopoietic cells? Prostaglandins Leukotrienes Essent Fatty Acids 1993;48:123-6.
18. Eling TE, Glasgow WC. Cellular proliferation and lipid metabolism: importance of lipoxygenases in modulating epidermal growth-factor mitogenesis. Cancer Metastasis Rev 1994;13: 397-410.
19. Britten RJ, Davisdon EH. Gene regulation for higher cells. A theory. Science 1969;145:349-57.
20. Anderson KM, Ondrey F, Harris JE. ETYA, a pleotropic membrane-active arachidonic acid analogue affects multiple signal transduction pathways in cultured transformed mammalian cells. Clin Biochem 1992;15:1-9.
21. Haliday EM, Ramesha CS, Ringold G. TNF induced c-fos via a novel pathway requiring conversion of arachidonic acid to a lipoxygenase metabolite. EMBO J 1991;10:109-15.
22. Anderson KM, Seed T, Meng J, et al. Five-lipoxygenase inhibitors reduce PANC-1 survival: the mode of cell death and synergism of MK886 with gamma linolenic acid. Anticancer Res 1998;18:791-800.
23. Hata S, Sugama K, You-Li Z, et al. Synthesis of sterols and 5-lipoxygenase products are required for the G1-S phase transition of interleukin 2-dependent lymphocyte proliferation. Microbiol Immunol 1987;31:1231-44.
24. Tang DG, Chen YQ, Honn KV. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc Natl Acad Sci USA 1996;93:5241-6.
25. Anderson KM, Seed T, Meng J, Harris JE. Searle SC-41661A, a selective inhibitor of 5-lipoxygenase induced apoptosis in androgen-independent human prostate (PC3) cancer cells. Proc Am Soc Clin Oncol 1995;14(27):79.
26. Anderson KM, Seed Y, Vos M et al, 1998. 5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate non-necrotic cell death. The Prostate, 1998 (in press).
27. Ghosh J, Myers CE. Arachidonic acid stimulated prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun 1997;235:418-23.
28. Avis IM, Jett M, Boyle T, et al. Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J Clin Invest 1996;97(3):806-13.
29. Slater AFG, Nobel CSL, Maellaro E, et al. Nitrone spin traps and a nitroxide antioxidant inhibit a common pathway of thymocyte apoptosis. Biol J 1995;306:771-8.
30. Anderson KM, Alrefrai W, Jajeh A, et al. Induction of type 1 programmed cell death in U937 cells by an antioxidant or the free radical spin trap NTBN. Proc Am Assoc Cancer Res 1998;39:3936.
31. Funk CD, Gunne H, Steiner H, et al. Native and mutant 5-lipoxygenase expression in a baculovirus/insect cell system. Proc Natl Acad Sci USA 1989;86:2592-6.
32. Anderson KM, Levin J, Jejah A, et al. Induction of apoptosis in blood cells from a patient with acute myelogenous leukemia by SC41661A, a selective inhibitor of 5-lipoxygenase. Prostaglandins Leukotrienes Essent Fatty Acids 1993;48:323-6.
33. Anderson KM, Seed T, Plate J, et al. Selective inhibition of 5-lipoxygenase reduced CML blast cell proliferation and induce limited differentiation followed by apoptosis. Leuk Res 1995;11: 789-801.
34. Anderson KM, Seed T, Jajeh A, et al. An in vivo inhibitor of 5-lipoxygenase, MK886, at micromolar concentration induced apoptosis in U937 and CML cells. Anticancer Res 1996;11: 2589-600.
35. Anderson KM, Ondrey FG, Harris JE, 1998. Modulation of cellular proliferation and induction of apoptosis in a human lymphoma cell line after treatment with selective lipoxygenase inhibitors. 5th Int Conf on Eicosanoids, La Jolla CA, abstract 94.
36. Byun T, Dudeja P, Harris JE, et al. A 5-lipoxygenase inhibitor at micromolar concentration raises intracellular calcium in U937 cells prior to their physiologic cell death. Prostaglandins Leukotrienes Essent Fatty Acids 1996;56:69-77.
37. McConkey DJ, Zhivotovsky B, Orrenius S. Apoptosis-molecular mechanisms and biomedical implications. Mol Asp Med 1996;17(3):23.
38. Peppelenbosch MP, Tertooten LGJ, Den Hertog J, de Last SW. Epidermal growth factor activates calcium channels by phospholipase A2/5-lipoxygrenase-mediated leukotriene C4 production. Cell 1992;69:295-303.
39. Look AT. Oncogenic transcription factors in the human acute leukemias. Science 1997;278:1059-64.
40. Stankova J, Rola-Pleszczynski M, Dubois CM. Granulocyte-macrophage colony-stimulating factor increases 5-lipoxygenase gene transcription and protein expression in human neutrophils. Blood 1995;85:3719-26.
41. Stuhlmeiert KM, Kao JJ, Bach FA. Arachidonic acid influences proinflammatory gene induction by stabilizing the inhibitor kBa/ nuclear factor-kB (NF-kB) complex, thus suppressing the nuclear translocation of NF-kB. J Biol Chem 1997;272:24679-83.
42. Kozubik A, Hofmanova J, Dusek L, Musilova E. 5-Lipoxygenase inhibitors potentiate effects of TGF-b1 on the differentiation of human leukemia HL-60 cells. J Leukotriene Biol 1997;62:240-8.
43. Stenka L, Lauren L, Reizenstein P, Lindgren JA. Leukotriene production by fresh bone marrow cells: evidence of altered lipoxygenase activity in chronic myelocytic leukemia. Exp Hematol 1987;15:203-7.
44. Feltenmark S, Runarsson G, Larsson P, et al. Diverse expression of cytosolic phospholipase A2, 5-lipoxygenase and prostaglandin H synthetase 2 in acute pre-B-lymphocytic leukaemia cells. Br J Haematol 1995;90:585-94.
45. Kozubik A, Hofmanova J, Pospisil M, et al. Effects of drugs inhibiting prostaglandin or leukotriene biosynthesis on postirradiation hematopoiesis in mouse. Int J Radiat Biol 1994;65:369-77.
46. Korystov YN, Dobrovinskaya OR, Shaposhnikova W, Eidus LKH. Role of arachidonic acid metabolism in thymocyte apoptosis after irradiation. FEBS Lett 1996;388(2, 3):238-41.
47. Murray A, Hung T, 1993. The Cell Cycle, an Introduction. WH Freeman, NY, pp 89-152.
48. Anderson KM, Bonomi P, Meng J, Harris JE. Inhibition of cancer cell proliferation by disruption of interdigitated/concatenated hierarchies of metabolic control/implementation processes: a proposal. Med Hypotheses 1998;50:119-23.
49. Trosko JE. Hierarchical and cybernetic nature of biologic systems and their relevance to homeostatic adaptation to low-level exposures to oxidative stress-inducing agents. Environ Health Perspect 1998;106(Suppl 1):331-8.
50. Koller M, Wachtler P, David A, et al. Arachidonic acid induces DNA-fragmentation in human polymorphonuclear neutrophil granulocytes. Inflammation 1997;21(5):463-74.